# Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset

> **NCT04962178** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 366 (estimated)

## Conditions studied

- ST-segment Elevation Myocardial Infarction (STEMI)

## Interventions

- **PROCEDURE:** Primary PCI
- **OTHER:** Optimal medical therapy with primary PCI not performed

## Key facts

- **NCT ID:** NCT04962178
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-09
- **Primary completion:** 2023-12
- **Final completion:** 2024-06
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962178, "Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04962178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*